RAMM Pharma Corp. reported earnings results for the third quarter and nine months ended July 31, 2022. For the third quarter, the company reported sales was CAD 0.888059 million compared to CAD 0.999276 million a year ago. Net loss was CAD 1.14 million compared to CAD 3.12 million a year ago. Basic loss per share from continuing operations was CAD 0.0093 compared to CAD 0.0302 a year ago.
For the nine months, sales was CAD 2.71 million compared to CAD 3.07 million a year ago. Net loss was CAD 4.51 million compared to CAD 5 million a year ago. Basic loss per share from continuing operations was CAD 0.0367 compared to CAD 0.0483 a year ago.